Risk factors for cataracts in systemic lupus erythematosus (SLE)

被引:26
|
作者
Alderaan, Khaled [1 ,2 ]
Sekicki, Vuk [3 ]
Magder, Laurence S. [4 ]
Petri, Michelle [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21205 USA
[2] King Fahad Specialist Hosp, Rheumatol Sect, Dammam, Saudi Arabia
[3] St Agnes Hosp, Dept Internal Med, Baltimore, MD 21229 USA
[4] Univ Maryland, Baltimore, MD 21201 USA
关键词
Cataract; Predictor; Frequency; Systemic lupus erythematosus; POSTERIOR SUBCAPSULAR CATARACTS; AGE-RELATED CATARACT; BLUE MOUNTAINS EYE; RHEUMATOID-ARTHRITIS; CIGARETTE-SMOKING; REVISED CRITERIA; LENS OPACITIES; BLOOD-PRESSURE; CORTICOSTEROIDS; NUCLEAR;
D O I
10.1007/s00296-014-3129-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cataract is the most common ocular damage in systemic lupus erythematosus (SLE). We analyzed data from the Hopkins Lupus Cohort longitudinally to identify the factors that predict onset of cataract prior to 60 years of age. The Hopkins Lupus Cohort is a clinical cohort of patients with SLE seen quarterly. This analysis was based on the follow-up experience prior to age 60 of 2,109 SLE patients who had not had a cataract prior to cohort entry. Patients saw their ophthalmologist every 6 months. Cataract was defined by the SLICC/American College of Rheumatology Damage Index. The rate of incident cataract was calculated in subsets of the follow-up defined by patient characteristics and history. Multivariable logistic regression models were fit to identify predictors of cataract while controlling for potential confounding variables. The analysis was based on 11,887 persons-years of follow-up, with median follow-up time of 4.1 years per patient. The incidence of cataract was 13.2/1,000 persons-years. Adjusting for other predictors, a cumulative prednisone dose equivalent to 10 mg/day for 10 years was a strong predictor of cataract (RR = 2.9, P = 0.0010). Disease activity measured by SELENA-SLEDAI (P = 0.0004) and higher systolic blood pressure (P = 0.0003) were associated with cataract. Duration of SLE, diabetes mellitus, smoking, cholesterol, renal involvement, immunological profile and medication history other than prednisone were not associated with cataract. Cataract development in SLE patients is multifactorial with prednisone, systolic blood pressure and disease activity all playing a role.
引用
下载
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [31] Contraception in Systemic Lupus Erythematosus (SLE)
    Shaukat, Faizan
    Keeling, Stephanie
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2019, 5 (04) : 346 - 362
  • [32] Etiopathogenesis of systemic lupus erythematosus (SLE)
    Herrmann, M
    Voll, RE
    Kolowos, W
    Lorenz, HM
    Kalden, JR
    IMMUNOLOGIST, 2000, 8 (03): : 66 - 71
  • [33] Hypertrichosis in systemic lupus erythematosus (SLE)
    Santiago, M
    Travassos, AC
    Rocha, MC
    Souza, S
    CLINICAL RHEUMATOLOGY, 2000, 19 (03) : 245 - 246
  • [34] Pathogenesis of systemic lupus erythematosus (SLE)
    Robson, MG
    Walport, MJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (05): : 678 - 685
  • [35] Thymectomy and systemic lupus erythematosus (SLE)
    Panarese, Alessandra
    D'Andrea, Vito
    Pironi, Daniele
    Filippini, Angelo
    ANNALI ITALIANI DI CHIRURGIA, 2014, 85 (06) : 617 - 618
  • [36] Contraception in Systemic Lupus Erythematosus (SLE)
    Faizan Shaukat
    Stephanie Keeling
    Current Treatment Options in Rheumatology, 2019, 5 : 346 - 362
  • [37] DEVELOPMENT OF ATHEROSCLEROSIS IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): THE CONTRIBUTION OF CLASSIC FRAMINGHAM RISK FACTORS
    Ahmad, Y.
    Bodill, H.
    El-Magadmi, M.
    Walker, M. G.
    Bernstein, R. M.
    Shelmerdine, J.
    Bruce, I. N.
    RHEUMATOLOGY, 2003, 42 : 77 - 77
  • [38] Critical peripheral ischaemia in systemic lupus erythematosus (SLE): Associated risk factors and therapy.
    Jeffery, Rachel C.
    Isenberg, David A.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S433 - S433
  • [39] Osteoporosis and risk factors in women with systemic lupus erythematosus (SLE): A case-control study
    Mok, Chi Chiu
    Ho, Ling Yin
    Yu, Ka Lung
    To, Chi Hung
    Leung, Tung Yeung
    Ma, Kwok Man
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S807 - S807
  • [40] RISK FACTORS FOR HOSPITALIZATION IN SYSTEMIC ERYTHEMATOSUS LUPUS (SLE). WHAT IS AT STAKE IN THE FIRST YEAR OF THE DISEASE?
    Schiliro, D.
    Trentin, F.
    Signorini, V.
    Elefante, E.
    Stagnaro, C.
    Carli, L.
    Ferro, F.
    Zucchi, D.
    Maffi, M.
    Gualtieri, L.
    Valevich, A.
    Cascarano, G.
    Tani, C.
    Mosca, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1497 - 1497